- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis shows that the financial resources of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are highly valuable as these help in investing into external opportunities that arise. These also help Drug Eluting Stents A Paradigm Shift in the Medical Device Industry in combating external threats.
- According to the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis shows that Drug Eluting Stents A Paradigm Shift in the Medical Device Industry's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry's products.
- According to the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. These patents also provide Drug Eluting Stents A Paradigm Shift in the Medical Device Industry with licensing revenue when it licenses these patents out to other manufacturers.
- The Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis shows that Drug Eluting Stents A Paradigm Shift in the Medical Device Industry’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis shows that the research and development at Drug Eluting Stents A Paradigm Shift in the Medical Device Industry is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are found to be rare according to the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Drug Eluting Stents A Paradigm Shift in the Medical Device Industry and inhibit competitive advantage. This means that the local food products result in competitive parity for Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. As this resource is valuable, Drug Eluting Stents A Paradigm Shift in the Medical Device Industry can still make use of this resource.
- The employees of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are a rare resource as identified by the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are a rare resource as identified by the Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Drug Eluting Stents A Paradigm Shift in the Medical Device Industry to use them without interference from the competition.
- The distribution network of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry is a rare resource as identified by the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are costly to imitate as identified by the Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Drug Eluting Stents A Paradigm Shift in the Medical Device Industry provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are also not costly to imitate as identified by the Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Drug Eluting Stents A Paradigm Shift in the Medical Device Industry by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are very difficult to imitate as identified by the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry is also very costly to imitate by competition as identified by the Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis. This has been developed over the years gradually by Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are organised to capture value as identified by the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Drug Eluting Stents A Paradigm Shift in the Medical Device Industry.
- The Patents of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry are not well organised as identified by the Drug Eluting Stents A Paradigm Shift in the Medical Device Industry VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Drug Eluting Stents A Paradigm Shift in the Medical Device Industry starts selling patented products before the patents expire.
- The distribution network of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry is organised as identified by the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry. Drug Eluting Stents A Paradigm Shift in the Medical Device Industry uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Drug Eluting Stents A Paradigm Shift in the Medical Device Industry.
From the VRIO Analysis of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Drug Eluting Stents A Paradigm Shift in the Medical Device Industry is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Arlo Brandet
5.0
All the subjective and objective questions were cleared up by this service. I called the scholar to make a change in one question and he edited it promptly. Much thanks!
Aliez Kalman
5.0
A famous company with a very fast and active system. I have no hesitation in suggesting this service to my fellows. Thanks!
Racheal Veraj
5.0
They were top-notch in providing the perfect assignment. The worth mentioning efforts of this service!
Jessica Stewart
5.0
Pleased to find no plagiarism in the report that you guys delivered to me. The assignment was error-free. Thank you!
Next Articles
- American Cyanamid (B): Management's Response To The (A) Case Vrio Analysis
- Abbott Laboratories And HUMIRA: Launching A Blockbuster Drug (Condensed) Vrio Analysis
- Knowledge Creation At Eisai Co., Ltd. Vrio Analysis
- Orthoteks USA (B2) Vrio Analysis
- Building A Scalable Business With Small Holder Farmers In Kenya: Honey Care's Beekeeping Model Vrio Analysis
- Zoll Medical Corp. (A) Vrio Analysis
- American Cyanamid (A) & (B) (Combined) Vrio Analysis
- Negotiating Strategic Alliances Vrio Analysis
- Entrepreneurship Goes Global: ResMed's Gamble Vrio Analysis
- Digital Microscopy Is Making Me Crazy! Vrio Analysis
Previous Articles
- Orthoteks USA (C) Vrio Analysis
- Amgen Inc.: Pursuing Innovation And Imitation? (A) Vrio Analysis
- Takeda Pharmaceutical Company (C): The Future Of Takeda Vrio Analysis
- Genzyme Corp.: Strategic Challenges With Ceredase Vrio Analysis
- Crestor Vrio Analysis
- Amgen Inc.'s Epogen Commercializing The First Biotech Blockbuster Drug Vrio Analysis
- Building The Virtual Lab: Global Licensing And Partnering At Merck Vrio Analysis
- The Highly Regulated German Medical Supplies Industry (A) Vrio Analysis
- At A Crossroads: The Strategic Dilemma At PENPOL Vrio Analysis
- Zandu Pharmaceutical Works: The Takeover Bid (A) Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!